홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Diisopropylamine → 3-fluoro-5-(4-methylpiperidin-1-yl)-N-[4-(2-morpholin-4-ylethoxy)-1-naphthyl]benzamide

HRID 1171366
인쇄

반응식

HRID 1171366 반응식
[N:1]1([CH2:7][CH2:8][O:9][C:10]2[C:19]3[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=3)[C:13]([NH2:20])=[CH:12][CH:11]=2)[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.[F:21][C:22]1[CH:23]=[C:24]([CH:28]=[C:29]([N:31]2[CH2:36][CH2:35][CH:34]([CH3:37])[CH2:33][CH2:32]2)[CH:30]=1)[C:25](O)=[O:26].CC1CCNCC1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(NC(C)C)(C)C>CN(C=O)C.C(Cl)Cl>[F:21][C:22]1[CH:23]=[C:24]([CH:28]=[C:29]([N:31]2[CH2:36][CH2:35][CH:34]([CH3:37])[CH2:33][CH2:32]2)[CH:30]=1)[C:25]([NH:20][C:13]1[C:14]2[C:19](=[CH:18][CH:17]=[CH:16][CH:15]=2)[C:10]([O:9][CH2:8][CH2:7][N:1]2[CH2:6][CH2:5][O:4][CH2:3][CH2:2]2)=[CH:11][CH:12]=1)=[O:26]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 7912DiisopropylamineHCID 693814-MethylpiperidineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 110439124-(2-Morpholinoethoxy)naphthalen-1-amineHCID 595533113-Fluoro-5-(4-methylpiperidin-1-yl)benzoic acid

생성물 1

HCID 59553173
3-fluoro-5-(4-methylpiperidin-1-yl)-N-[4-(2-morpholin-4-ylethoxy)-1-naphthyl]benzamide
수율 49%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매

실험 절차

To a solution of [4-(2-morpholin-4-ylethoxy)-1-naphthyl]amine (0.60 g, 2.2 mmol) in DMF (2 ml) is added 3-fluoro-5-(4-methylpiperidin-1-yl)benzoic acid (0.63 g, 2.64 mmol), prepared from 4-methylpiperidine according to conditions described in general procedure E, HBTU (1.25 g, 3.3 mmol) and diisopropylamine (1.15 ml, 6.6 mmol). This mixture is stirred at room temperature overnight and diluted with CH2Cl2 (5 ml), washed with 0.05 N NaOH, dried over Na2SO4 and concentrated. The residue is purified by column chromatography on silica gel (90% EtOAc in hexane) to give 3-fluoro-5-(4-methylpiperidin-1-yl)-N-[4-(2-morpholin-4-ylethoxy)-1-naphthyl]benzamide as a white solid (0.53 g). Mp: 116-118° C.; 1H NMR (300 MHz, DMSO-d6) δ 0.91 (d, 6.3 Hz, 3H), 1.15-1.25 (m, 2H), 1.67 (d, J=12 Hz, 2H), 2.55 (bs, 4H), 2.74 (t, J=12.3 Hz, 2H), 2.86 (s, 2H), 3.59 (t, J=4.5 Hz, 4H), 3.82 (d, J=12.9 Hz, 2H), 4.29 (t, J=5.7 Hz, 2H), 6.93 (d, J=12.6 Hz, 1H), 7.00 (d, J=8.1Hz, 1H), 7.12 (d, J=8.7 Hz, 1H), 7.37-7.43 (m, 2H), 7.51-7.55 (m, 2H), 7.81-7.84 (m, 1H), 8.17-8.20 (m, 1H), 10.21 (s, 1H); MS 492 (M+1).

후처리

  1. washwashed with 0.05 N NaOH
  2. dry with materialdried over Na2SO4
  3. concentrationconcentrated
  4. customThe residue is purified by column chromatography on silica gel (90% EtOAc in hexane)

출처 및 근거

ORD 기록
ord-d74b36897d1e499ca006e79d1670b790
출처 데이터셋
uspto-grants-2010_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07829560B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트